MERCK / MILLIPORESIGMA
Learn how Protacs work for targeted protein degradation to widen the spectrum of targetable proteins Targeted protein degradation (TPD) is an emerging drug discovery strategy that allows access to difficult-to-treat diseases. While traditional small-molecule drugs may only allow access to ~20% of the proteome, degradation techniques may open the door to the other 80%. Proteolysis targeting chimeras (Protacs) are an attractive new means of protein degradation, and work catalytically at sub-stoichiometric levels over an extended length of time. These tools have the potential to widen the spectrum of targetable proteins, including proteins that have proven intractable to traditional approaches.
Watch Now
Net at Work
With ever-changing compliance rules and greater complexity, disjointed systems or too costly market solutions are the enemies of chemical manufacturers & distributors – occurring when ERP, CRM, & supply chain processes are allowed to operate in silos. Thankfully, today’s business management solutions have been evolving to meet the industry’s complex demands. Join this live web demo for a look at why Sage X3 is the choice for the fast growing chemical enterprise. See firsthand how with Sage X3 you can achieve:
Watch Now
How can production costs be reduced with rising raw material costs? What are the advantages of looking at new technologies in injection molding and what solutions
Watch Now
Chemical recycling refers to an emerging and diverse group of technologies for which there is a need for well-founded data to assess their potential contribution to circularity and decarbonisation. To support decision-making and investment processes, life cycle assessment (LCA) is a key tool for assessing the impacts of these technologies.
Watch Now